Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merck & Co. describes new MCH1 antagonists, their preparation and use

June 27, 2003

Cyclic peptide with sst receptor-agonist activity identified by SCRAS scientists

June 27, 2003

Good safety and efficacy described for rasburicase in cancer patients with hyperuricemia

June 27, 2003

DW-1350 inhibits bone resorption and enhances bone formation

June 27, 2003

Steroidal estrogen agonist from J&J characterized in vitro and in vivo

June 26, 2003

Insmed's rhIGF-I/rhIGFBP-3 granted orphan drug designation in Europe

June 26, 2003

Positive interim results for Tostrelle in female sexual dysfunction

June 26, 2003

Takeda researchers present new somatostatin receptor ligands in recent patent

June 26, 2003

BIM-23190 reduces serum insulin and growth hormone levels in type 2 diabetes

June 26, 2003

Somatostatin receptor ligands and their use in acromegaly and other disorders

June 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...